✦ LIBER ✦

Lapatinib, a Dual ErbB-1/ErbB-2 Kinase Inhibitor, in the Treatment of HER2-Overexpressing Locally Advanced and Metastatic Breast Cancer

✍ Scribed by Susan R. Peck; Joyce A. O'Shaughnessy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of ErbB1 and ErbB2 by Lapatin

✍ Kavita Maung; Joyce A. O'Shaughnessy 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 90 KB

Combining lapatinib (GW572016), a small

✍ Xia, Wenle; Gerard, Catherine M; Liu, Leihua; Baudson, Nathalie M; Ory, Thierry 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 235 KB

3509 POSTER Growth inhibitory effects an

✍ J.W. Kim; S.A. Im; H.P. Kim; D.Y. Oh; T.Y. Kim; Y.J. Bang 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

A phase II, randomized, multicenter stud

✍ Janni, Wolfgang; Sarosiek, Tomasz; Karaszewska, Boguslawa; Pikiel, Joanna; Staro 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 399 KB

A Phase I/II Trial of Trastuzumab and Ge

✍ Stacy L. Moulder; Carlos L. Arteaga 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 440 KB

A specific VEGF-R tyrosine kinase inhibi

✍ Elizabeth Min Hui Kim; Catherine Lobocki; Linda Dubay; Vijay Mittal 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB